Cargando…

Increased Sialylation of Anti-Thomsen-Friedenreich Antigen (CD176) Antibodies in Patients with Gastric Cancer: A Diagnostic and Prognostic Potential

Aim. To study whether alterations in the sialylation of antibodies (Ab) specific to the Thomsen-Friedenreich (TF) glycotope have a diagnostic and prognostic potential in gastric cancer. Methods. Serum samples were taken from patients with gastric carcinoma (n = 142) and controls (n = 61). The level...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurtenkov, Oleg, Izotova, Jelena, Klaamas, Kersti, Sergeyev, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168149/ https://www.ncbi.nlm.nih.gov/pubmed/25276822 http://dx.doi.org/10.1155/2014/830847

Ejemplares similares

The Thomsen-Friedenreich Antigen-Specific Antibody Signatures in Patients with Breast Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2018)

Increased Avidity of the Sambucus nigra Lectin-Reactive Antibodies to the Thomsen-Friedenreich Antigen as a Potential Biomarker for Gastric Cancer
por: Kurtenkov, Oleg, et al.
Publicado: (2015)

Hidden IgG Antibodies to the Tumor-Associated Thomsen-Friedenreich Antigen in Gastric Cancer Patients: Lectin Reactivity, Avidity, and Clinical Relevance
por: Kurtenkov, Oleg, et al.
Publicado: (2017)

Profiling of Naturally Occurring Antibodies to the Thomsen-Friedenreich Antigen in Health and Cancer: The Diversity and Clinical Potential
por: Kurtenkov, Oleg
Publicado: (2020)

A One-Step Chemoenzymatic Labeling Strategy for Probing Sialylated Thomsen–Friedenreich Antigen
por: Wen, Liuqing, et al.
Publicado: (2018)

CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
por: Dragon, Anna Christina, et al.
Publicado: (2023)

The role of the Thomsen-Friedenreich antigen as a tumor-associated molecule.
por: Dippold, W, et al.
Publicado: (1990)

The Relation of the Level of Serum Anti-TF, -Tn and -Alpha-Gal IgG to Survival in Gastrointestinal Cancer Patients
por: Smorodin, Eugeniy, et al.
Publicado: (2013)

Interaction of the Oncofetal Thomsen–Friedenreich Antigen with Galectins in Cancer Progression and Metastasis
por: Sindrewicz, Paulina, et al.
Publicado: (2016)

Expression of Thomsen–Friedenreich Antigen in Colorectal Cancer and Association with Microsatellite Instability
por: Leão, Beatriz, et al.
Publicado: (2021)

The Thomsen-Friedenreich Antigen: A Highly Sensitive and Specific Predictor of Microsatellite Instability in Gastric Cancer
por: Mereiter, Stefan, et al.
Publicado: (2018)

Structural Basis for Distinct Binding Properties of the Human Galectins to Thomsen-Friedenreich Antigen
por: Bian, Cheng-Feng, et al.
Publicado: (2011)

Contribution of Thomsen-Friedenreich antigens to bladder cancer malignancy: Characterization of cell line models
por: Severino, Paulo F, et al.
Publicado: (2010)

Synthesis of the Thomsen-Friedenreich-antigen (TF-antigen) and binding of Galectin-3 to TF-antigen presenting neo-glycoproteins
por: Hoffmann, Marius, et al.
Publicado: (2020)

Enhanced Immune Response Against the Thomsen-Friedenreich Tumor Antigen Using a Bivalent Entirely Carbohydrate Conjugate
por: Kleski, Kristopher A., et al.
Publicado: (2020)

Exposure of Thomsen-Friedenreich Antigen on the Renal Tubules of a Patient with Capnocytophaga Infection-induced Acute Kidney Injury
por: Uchida, Takahiro, et al.
Publicado: (2021)

Determination of thermodynamic parameters of Xerocomus chrysenteron lectin interactions with N-acetylgalactosamine and Thomsen-Friedenreich antigen by isothermal titration calorimetry
por: Damian, Luminita, et al.
Publicado: (2005)

Glycoamino Acid Analogues of the Thomsen–Friedenreich Tumor-Associated Carbohydrate Antigen: Synthesis and Evaluation of Novel Antiproliferative Factor Glycopeptides
por: Siddiqui, Maqbool A., et al.
Publicado: (2017)

Isolipoic acid-linked gold nanoparticles bearing the thomsen friedenreich tumor-associated carbohydrate antigen: Stability and in vitro studies
por: Mondal, Utpal K., et al.
Publicado: (2022)

Evaluation of a novel fluorescent nanobeacon for targeted imaging of Thomsen-Friedenreich associated colorectal cancer
por: Nakase, Hiroshi, et al.
Publicado: (2017)

The Potential Action of Thomsen–Friedenreich Monoclonal Antibody (A78-G/A7) in Thyroid Cancer
por: Peng, Ying, et al.
Publicado: (2020)

Identification and Targeting of Thomsen–Friedenreich and IL1RAP Antigens on Chronic Myeloid Leukemia Stem Cells Using Bi-Specific Antibodies
por: Eldesouki, Raghda E, et al.
Publicado: (2021)

Preclinical Analysis of JAA-F11, a Specific Anti–Thomsen-Friedenreich Antibody via Immunohistochemistry and In Vivo Imaging
por: Karacosta, Loukia G., et al.
Publicado: (2018)

Treatment of ovarian cancer by targeting the tumor stem cell-associated carbohydrate antigen, Sialyl-Thomsen-nouveau
por: Starbuck, Kristen, et al.
Publicado: (2018)

Association of the Sialylation of Antibodies Specific to the HCV E2 Envelope Glycoprotein with Hepatic Fibrosis Progression and Antiviral Therapy Efficacy
por: Kurtenkov, Oleg, et al.
Publicado: (2020)

Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and InVitro Efficacy Analysis
por: Tati, Swetha, et al.
Publicado: (2017)

Cell surface Thomsen-Friedenreich proteome profiling of metastatic prostate cancer cells reveals potential link with cancer stem cell-like phenotype
por: Li, Feng, et al.
Publicado: (2017)

Synthesis and biological evaluation of a novel MUC1 glycopeptide conjugate vaccine candidate comprising a 4’-deoxy-4’-fluoro-Thomsen–Friedenreich epitope
por: Johannes, Manuel, et al.
Publicado: (2015)

Corrigendum to “Humanization of JAA-F11, a Highly Specific Anti-Thomsen-Friedenreich Pancarcinoma Antibody and In Vitro Efficacy Analysis” [Neoplasia 19.9 (2017) 716-733]
por: Tati, Swetha, et al.
Publicado: (2017)

Thomsen and myotonia congenita.
por: Johnson, J
Publicado: (1968)

IgG Antibodies to GlcNAcβ and Asialo-GM2 (GA2) Glycans as Potential Markers of Liver Damage in Chronic Hepatitis C and the Efficacy of Antiviral Treatment
por: Smorodin, Eugeniy, et al.
Publicado: (2018)

Myotonia Congenita. Thomsen's Disease
por: Variava, N. S.
Publicado: (1949)

Myotonia Congenita (Thomsen's Disease)
por: Chand, Amir, et al.
Publicado: (1945)

Therapeutic efficacy of the humanized JAA-F11 anti-Thomsen-Friedenreich antibody constructs H2aL2a and H3L3 in human breast and lung cancer xenograft models
por: Ghazal, Diala, et al.
Publicado: (2022)

A New Neurosis. (Thomsen's Disease)
por: Spencer, William H.
Publicado: (1884)

Thomsen’s Disease—A Family History
por: Clemesha, J. C.
Publicado: (1897)

Combined evaluation of preoperative serum sialyl-Tn antigen and carcinoembryonic antigen levels is prognostic for gastric cancer patients.
por: Takahashi, I., et al.
Publicado: (1994)

Correction to Boeg Thomsen et al. (2021)
Publicado: (2022)

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors.
por: Miles, D. W., et al.
Publicado: (1995)

A Case of Myotonia Congenita (Thomsen's Disease) in a Child
por: Thomson, John
Publicado: (1916)

Cannot write session to /tmp/vufind_sessions/sess_beqsk5nba8efu737lgc3i8nfrn